Molecular mechanisms in the initiation phase of Wallerian degeneration

详细信息    查看全文

• 作者：Biao Chang ; Qi Quan ; Shibi Lu ; Yu Wang and Jiang Peng
• 刊名：European Journal of Neuroscience
• 出版年：2016
• 出版时间：August 2016
• 年：2016
• 卷：44
• 期：4
• 页码：2040-2048
• 全文大小：197K
• ISSN：1460-9568

文摘

Axonal degeneration is an early hallmark of nerve injury and many neurodegenerative diseases. The discovery of the Wallerian degeneration slow mutant mouse, in which axonal degeneration is delayed, revealed that Wallerian degeneration is an active progress and thereby illuminated the mechanisms underlying axonal degeneration. Nicotinamide mononucleotide adenylyltransferase 2 and sterile alpha and armadillo motif-containing protein 1 play essential roles in the maintenance of axon integrity by regulating the level of nicotinamide adenine dinucleotide, which seems to be the key molecule involved in the maintenance of axonal health. However, the function of nicotinamide mononucleotide remains debatable, and we discuss two apparently conflicting roles of nicotinamide mononucleotide in Wallerian degeneration. In this article, we focus on the roles of these molecules in the initiation phase of Wallerian degeneration to improve our understanding of the mechanisms underpinning this phenomenon.